Goal · Longevity

≈7 min · no account

Usually lands on · NAD+ / MOTS-C / Epitalon

Can end at no pen

Serious about ageing well?

Longevity is where marketing runs furthest ahead of evidence. Three pens in the range are researched for healthy ageing — NAD+, MOTS-C and Epitalon — with early human data at best. The Peptide Checkup shows the grade before it shows the pen.

01 — Where the Checkup usually lands

3 pens are researched for longevity.

Human evidence for NAD+ exists mainly for oral precursors and small intravenous studies; MOTS-C and Epitalon have animal data and little else. None has outcome data for ageing in people, and the Checkup says so. Your answers decide — including whether to buy at all.

02 — What the Checkup checks

Four things it checks for longevity.

7 minutes of structured questions — categories, not essays — run through a deterministic rules engine against the evidence and regulatory database, then scored against the range.

  1. 01What human data exists for NAD+, MOTS-C and Epitalon — oral precursors, small intravenous studies, animal models, uncontrolled reports — and what does not
  2. 02Cardiovascular, metabolic and cancer history that changes the picture
  3. 03Interactions with long-term medicines such as statins, blood-pressure and diabetes medicines
  4. 04Anti-doping status of MOTS-C, and questions to ask a clinician about monitoring

Research-use pens

Sold for research use only. Not a medicine and not authorised for human consumption. Purchasers must be 18+ and confirm intended use at checkout.

Peptide Checkup

The Peptide Checkup provides educational information and a structured summary of published research and regulatory status. It is not medical advice, does not diagnose or treat any condition, and does not replace a consultation with a qualified healthcare professional.

Longevity

Take the 7-minute Checkup for longevity.

Not medical advice · Research-use labelling applies · 18+ only · It can say no